Free Trial

The Procter & Gamble Company (NYSE:PG) Position Increased by Charles Schwab Investment Management Inc.

Procter & Gamble logo with Consumer Staples background

Charles Schwab Investment Management Inc. raised its holdings in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 0.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,422,470 shares of the company's stock after buying an additional 105,734 shares during the period. Charles Schwab Investment Management Inc. owned about 0.70% of Procter & Gamble worth $2,844,442,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Itau Unibanco Holding S.A. acquired a new position in shares of Procter & Gamble during the second quarter worth $28,000. Fairway Wealth LLC acquired a new stake in Procter & Gamble in the second quarter valued at $29,000. POM Investment Strategies LLC acquired a new stake in Procter & Gamble in the second quarter valued at $34,000. Quest Partners LLC bought a new stake in Procter & Gamble during the second quarter valued at $36,000. Finally, Fairfield Financial Advisors LTD bought a new stake in Procter & Gamble during the second quarter valued at $44,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

NYSE PG traded up $1.79 on Thursday, reaching $172.68. The company's stock had a trading volume of 4,184,109 shares, compared to its average volume of 6,672,316. The Procter & Gamble Company has a twelve month low of $142.50 and a twelve month high of $177.94. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock has a market cap of $406.67 billion, a PE ratio of 29.77, a PEG ratio of 3.69 and a beta of 0.42. The firm's 50 day moving average is $170.00 and its two-hundred day moving average is $168.54.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same period last year, the company posted $1.83 EPS. The company's revenue was down .6% compared to the same quarter last year. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.33%. The ex-dividend date was Friday, October 18th. Procter & Gamble's payout ratio is 69.48%.

Insider Transactions at Procter & Gamble

In other news, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the sale, the chief executive officer now owns 13,783 shares in the company, valued at $2,343,110. This represents a 12.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the sale, the insider now owns 19,341 shares of the company's stock, valued at $3,319,882.65. The trade was a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 174,727 shares of company stock valued at $29,694,037 over the last ninety days. Corporate insiders own 0.18% of the company's stock.

Analyst Ratings Changes

PG has been the subject of several recent research reports. Hsbc Global Res upgraded shares of Procter & Gamble to a "strong-buy" rating in a research note on Friday, October 4th. DA Davidson reiterated a "neutral" rating and set a $160.00 target price on shares of Procter & Gamble in a research note on Wednesday. Dbs Bank lowered shares of Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 1st. Morgan Stanley boosted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a research note on Monday, October 21st. Finally, Wolfe Research upgraded shares of Procter & Gamble to a "strong-buy" rating in a research note on Friday, August 23rd. Nine investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $177.00.

View Our Latest Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines